Richard Fitzpatrick Ph.D., MBA
CEO, CSO, Flatley Discovery Lab
Richard Fitzpatrick is a co-founder of Flatley Discovery Lab (FDL) and serves as its CEO and CSO. FDL is a not-for-profit biotech focused on discovery and development of small molecule modulators of CFTR. Richard received his Ph.D. in Chemistry from The Pennsylvania State University and his MBA from Babson College. He has spent more than 20 years in biotechnology working on a wide variety of projects, including DNA and peptide synthesis, protein separation and purification, and drug discovery and development. Prior to FDL, Richard spent ten years at Genzyme Corporation as a Principal Scientist working in drug discovery for infectious disease, oncology, and metabolic indications.